abstract |
The present invention relates to novel sequences for use in the detection, diagnosis and treatment of cancer, in particular lymphomas. The present invention provides cancer associated (CA) polynucleotide sequences, the expression of which is associated with cancer. The present invention provides cancer related CA polypeptides that exhibit novel therapeutic targets for cancer. The invention further provides diagnostic compositions and methods for cancer detection. The present invention provides monoclonal and polyclonal antibodies specific for CA polypeptides. The invention also provides diagnostic tools, therapeutic compositions, and screening methods for the prevention and treatment of cancer. |